Finding the right dose: protecting new moms from dangerous clots
NCT ID NCT07342127
Summary
This study aims to find the best length of time to give blood-thinning medication to new mothers who have a specific genetic trait that increases their risk of developing dangerous blood clots after giving birth. Researchers will look back at the medical records of 100 women with this trait to see how long they were treated and then compare whether a shorter treatment (less than 2 weeks) or a longer one (6 weeks) is better at preventing clots while causing fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service Gynécologie Obstétrique - Hôpital de la Croix Rousse
Lyon, 69004, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service d'hémostase clinique - Hôpital Louis Pradel
Bron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.